EIF2A and Alzheimer disease: Moreover, in AD animal models, either β-amyloid oligomers or AD-associated toxins initiate the elevation of phosphorylated Eif2α, neuronal insulin receptor substrate inhibition, synapse loss, and cognition impairment through activating PKR (Lourenco et al., 2013).